Skip to main content
Erschienen in: Endocrine 2/2015

01.03.2015 | Original Article

Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2

verfasst von: Hongyu Guan, Weiwei Liang, Zhiwei Xie, Hai Li, Juan Liu, Liehua Liu, Lingling Xiu, Yanbing Li

Erschienen in: Endocrine | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Thyroid cancer is the most common endocrine malignancy, and its incidence has increased rapidly worldwide. The molecular mechanisms underlying thyroid cancer tumorigenesis still need to be further investigated. MicroRNAs (miRNAs), short RNA molecules of approximately 22 nucleotides in length, play crucial roles in tumorigenesis. In the present study, we found that the expression of miR-144 was significantly down-regulated in thyroid cancer as compared with that in normal thyroid tissues, suggesting that miR-144 may be involved in thyroid cancer tumorigenesis. Moreover, our results showed that restoration of miR-144 in K1 and WRO thyroid cancer cells could suppress the invasion and migration capability of these cells. We also demonstrated that miR-144 suppressed the expression of ZEB1 and ZEB2, two E-cadherin suppressors, by directly binding to their 3′-untranslated regions. Furthermore, restoration of ZEB1 or ZEB2 partially rescued the miR-144-induced inhibition of cell invasion. These data suggest miR-144 function as a tumor suppressor in thyroid cancer.
Literatur
1.
3.
Zurück zum Zitat V.V. Vasko, M. Saji, Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis. Curr. Opin. Oncol. 19, 11–17 (2007)CrossRefPubMed V.V. Vasko, M. Saji, Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis. Curr. Opin. Oncol. 19, 11–17 (2007)CrossRefPubMed
4.
Zurück zum Zitat Q. Yang, M. Ji, H. Guan, B. Shi, P. Hou, Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways. J. Clin. Endocrinol. Metab. 98, E1909–E1917 (2013)CrossRefPubMed Q. Yang, M. Ji, H. Guan, B. Shi, P. Hou, Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways. J. Clin. Endocrinol. Metab. 98, E1909–E1917 (2013)CrossRefPubMed
5.
6.
Zurück zum Zitat X.S. Ke, C.M. Liu, D.P. Liu, C.C. Liang, Micrornas: key participants in gene regulatory networks. Curr. Opin. Chem. Biol. 7, 516–523 (2003)CrossRefPubMed X.S. Ke, C.M. Liu, D.P. Liu, C.C. Liang, Micrornas: key participants in gene regulatory networks. Curr. Opin. Chem. Biol. 7, 516–523 (2003)CrossRefPubMed
7.
Zurück zum Zitat G.A. Calin, C.M. Croce, Microrna signatures in human cancers. Nat. Rev. Cancer 6, 857–866 (2006)CrossRefPubMed G.A. Calin, C.M. Croce, Microrna signatures in human cancers. Nat. Rev. Cancer 6, 857–866 (2006)CrossRefPubMed
8.
Zurück zum Zitat C.Z. Chen, Micrornas as oncogenes and tumor suppressors. N. Engl. J. Med. 353, 1768–1771 (2005)CrossRefPubMed C.Z. Chen, Micrornas as oncogenes and tumor suppressors. N. Engl. J. Med. 353, 1768–1771 (2005)CrossRefPubMed
10.
Zurück zum Zitat H. He, K. Jazdzewski, W. Li, S. Liyanarachchi, R. Nagy, S. Volinia, G.A. Calin, C.G. Liu, K. Franssila, S. Suster, R.T. Kloos, C.M. Croce, A. de la Chapelle, The role of microrna genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. USA 102, 19075–19080 (2005)CrossRefPubMedCentralPubMed H. He, K. Jazdzewski, W. Li, S. Liyanarachchi, R. Nagy, S. Volinia, G.A. Calin, C.G. Liu, K. Franssila, S. Suster, R.T. Kloos, C.M. Croce, A. de la Chapelle, The role of microrna genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. USA 102, 19075–19080 (2005)CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat J.C. Ricarte-Filho, C.S. Fuziwara, A.S. Yamashita, E. Rezende, M.J. da-Silva, E.T. Kimura, Effects of let-7 microrna on cell growth and differentiation of papillary thyroid cancer. Transl. Oncol. 2, 236–241 (2009)CrossRefPubMedCentralPubMed J.C. Ricarte-Filho, C.S. Fuziwara, A.S. Yamashita, E. Rezende, M.J. da-Silva, E.T. Kimura, Effects of let-7 microrna on cell growth and differentiation of papillary thyroid cancer. Transl. Oncol. 2, 236–241 (2009)CrossRefPubMedCentralPubMed
12.
Zurück zum Zitat H.M. Namlos, L.A. Meza-Zepeda, T. Baroy, I.H. Ostensen, S.H. Kresse, M.L. Kuijjer, M. Serra, H. Burger, A.M. Cleton-Jansen, O. Myklebost, Modulation of the osteosarcoma expression phenotype by micrornas. PLoS One 7, e48086 (2012)CrossRefPubMedCentralPubMed H.M. Namlos, L.A. Meza-Zepeda, T. Baroy, I.H. Ostensen, S.H. Kresse, M.L. Kuijjer, M. Serra, H. Burger, A.M. Cleton-Jansen, O. Myklebost, Modulation of the osteosarcoma expression phenotype by micrornas. PLoS One 7, e48086 (2012)CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat M. Guled, L. Lahti, P.M. Lindholm, K. Salmenkivi, I. Bagwan, A.G. Nicholson, S. Knuutila, Cdkn2a, nf2, and jun are dysregulated among other genes by mirnas in malignant mesothelioma-a mirna microarray analysis. Genes Chromosome Cancer 48, 615–623 (2009)CrossRef M. Guled, L. Lahti, P.M. Lindholm, K. Salmenkivi, I. Bagwan, A.G. Nicholson, S. Knuutila, Cdkn2a, nf2, and jun are dysregulated among other genes by mirnas in malignant mesothelioma-a mirna microarray analysis. Genes Chromosome Cancer 48, 615–623 (2009)CrossRef
14.
Zurück zum Zitat S. Akiyoshi, T. Fukagawa, H. Ueo, M. Ishibashi, Y. Takahashi, M. Fabbri, M. Sasako, Y. Maehara, K. Mimori, M. Mori, Clinical significance of mir-144-zfx axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br. J. Cancer 107, 1345–1353 (2012)CrossRefPubMedCentralPubMed S. Akiyoshi, T. Fukagawa, H. Ueo, M. Ishibashi, Y. Takahashi, M. Fabbri, M. Sasako, Y. Maehara, K. Mimori, M. Mori, Clinical significance of mir-144-zfx axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br. J. Cancer 107, 1345–1353 (2012)CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat S.M. Sureban, R. May, F.G. Mondalek, D. Qu, S. Ponnurangam, P. Pantazis, S. Anant, R.P. Ramanujam, C.W. Houchen, Nanoparticle-based delivery of sidcamkl-1 increases microrna-144 and inhibits colorectal cancer tumor growth via a notch-1 dependent mechanism. J. Nanobiotechnol. 9, 40 (2011)CrossRef S.M. Sureban, R. May, F.G. Mondalek, D. Qu, S. Ponnurangam, P. Pantazis, S. Anant, R.P. Ramanujam, C.W. Houchen, Nanoparticle-based delivery of sidcamkl-1 increases microrna-144 and inhibits colorectal cancer tumor growth via a notch-1 dependent mechanism. J. Nanobiotechnol. 9, 40 (2011)CrossRef
16.
Zurück zum Zitat L.Y. Zhang, V. Ho-Fun Lee, A.M. Wong, D.L. Kwong, Y.H. Zhu, S.S. Dong, K.L. Kong, J. Chen, S.W. Tsao, X.Y. Guan, L. Fu, Microrna-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of pten. Carcinogenesis 34, 454–463 (2013)CrossRefPubMed L.Y. Zhang, V. Ho-Fun Lee, A.M. Wong, D.L. Kwong, Y.H. Zhu, S.S. Dong, K.L. Kong, J. Chen, S.W. Tsao, X.Y. Guan, L. Fu, Microrna-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of pten. Carcinogenesis 34, 454–463 (2013)CrossRefPubMed
17.
Zurück zum Zitat S. Cahill, P. Smyth, K. Denning, R. Flavin, J. Li, A. Potratz, S.M. Guenther, R. Henfrey, J.J. O’Leary, O. Sheils, Effect of brafv600e mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model. Mol. Cancer 6, 21 (2007)CrossRefPubMedCentralPubMed S. Cahill, P. Smyth, K. Denning, R. Flavin, J. Li, A. Potratz, S.M. Guenther, R. Henfrey, J.J. O’Leary, O. Sheils, Effect of brafv600e mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model. Mol. Cancer 6, 21 (2007)CrossRefPubMedCentralPubMed
18.
Zurück zum Zitat M. Rossing, R. Borup, R. Henao, O. Winther, J. Vikesaa, O. Niazi, C. Godballe, A. Krogdahl, M. Glud, C. Hjort-Sorensen, K. Kiss, F.N. Bennedbaek, F.C. Nielsen, Down-regulation of micrornas controlling tumourigenic factors in follicular thyroid carcinoma. J. Mol. Endocrinol. 48, 11–23 (2012)CrossRefPubMed M. Rossing, R. Borup, R. Henao, O. Winther, J. Vikesaa, O. Niazi, C. Godballe, A. Krogdahl, M. Glud, C. Hjort-Sorensen, K. Kiss, F.N. Bennedbaek, F.C. Nielsen, Down-regulation of micrornas controlling tumourigenic factors in follicular thyroid carcinoma. J. Mol. Endocrinol. 48, 11–23 (2012)CrossRefPubMed
19.
Zurück zum Zitat M. Swierniak, A. Wojcicka, M. Czetwertynska, E. Stachlewska, M. Maciag, W. Wiechno, B. Gornicka, M. Bogdanska, L. Koperski, A. de la Chapelle, K. Jazdzewski, In-depth characterization of the microrna transcriptome in normal thyroid and papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 98, E1401–E1409 (2013)CrossRefPubMed M. Swierniak, A. Wojcicka, M. Czetwertynska, E. Stachlewska, M. Maciag, W. Wiechno, B. Gornicka, M. Bogdanska, L. Koperski, A. de la Chapelle, K. Jazdzewski, In-depth characterization of the microrna transcriptome in normal thyroid and papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 98, E1401–E1409 (2013)CrossRefPubMed
20.
Zurück zum Zitat S. Brabletz, T. Brabletz, The zeb/mir-200 feedback loop—a motor of cellular plasticity in development and cancer? EMBO Rep. 11, 670–677 (2010)CrossRefPubMedCentralPubMed S. Brabletz, T. Brabletz, The zeb/mir-200 feedback loop—a motor of cellular plasticity in development and cancer? EMBO Rep. 11, 670–677 (2010)CrossRefPubMedCentralPubMed
21.
Zurück zum Zitat E.M. Hurt, J.N. Saykally, B.M. Anose, K.R. Kalli, M.M. Sanders, Expression of the zeb1 (deltaef1) transcription factor in human: additional insights. Mol. Cell. Biochem. 318, 89–99 (2008)CrossRefPubMed E.M. Hurt, J.N. Saykally, B.M. Anose, K.R. Kalli, M.M. Sanders, Expression of the zeb1 (deltaef1) transcription factor in human: additional insights. Mol. Cell. Biochem. 318, 89–99 (2008)CrossRefPubMed
22.
Zurück zum Zitat J. Comijn, G. Berx, P. Vermassen, K. Verschueren, L. van Grunsven, E. Bruyneel, M. Mareel, D. Huylebroeck, F. van Roy, The two-handed e box binding zinc finger protein sip1 downregulates e-cadherin and induces invasion. Mol. Cell 7, 1267–1278 (2001)CrossRefPubMed J. Comijn, G. Berx, P. Vermassen, K. Verschueren, L. van Grunsven, E. Bruyneel, M. Mareel, D. Huylebroeck, F. van Roy, The two-handed e box binding zinc finger protein sip1 downregulates e-cadherin and induces invasion. Mol. Cell 7, 1267–1278 (2001)CrossRefPubMed
23.
Zurück zum Zitat K. Aigner, L. Descovich, M. Mikula, A. Sultan, B. Dampier, S. Bonne, F. van Roy, W. Mikulits, M. Schreiber, T. Brabletz, W. Sommergruber, N. Schweifer, A. Wernitznig, H. Beug, R. Foisner, A. Eger, The transcription factor zeb1 (deltaef1) represses plakophilin 3 during human cancer progression. FEBS Lett. 581, 1617–1624 (2007)CrossRefPubMedCentralPubMed K. Aigner, L. Descovich, M. Mikula, A. Sultan, B. Dampier, S. Bonne, F. van Roy, W. Mikulits, M. Schreiber, T. Brabletz, W. Sommergruber, N. Schweifer, A. Wernitznig, H. Beug, R. Foisner, A. Eger, The transcription factor zeb1 (deltaef1) represses plakophilin 3 during human cancer progression. FEBS Lett. 581, 1617–1624 (2007)CrossRefPubMedCentralPubMed
24.
Zurück zum Zitat T.R. Graham, H.E. Zhau, V.A. Odero-Marah, A.O. Osunkoya, K.S. Kimbro, M. Tighiouart, T. Liu, J.W. Simons, R.M. O’Regan, Insulin-like growth factor-i-dependent up-regulation of zeb1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res. 68, 2479–2488 (2008)CrossRefPubMed T.R. Graham, H.E. Zhau, V.A. Odero-Marah, A.O. Osunkoya, K.S. Kimbro, M. Tighiouart, T. Liu, J.W. Simons, R.M. O’Regan, Insulin-like growth factor-i-dependent up-regulation of zeb1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res. 68, 2479–2488 (2008)CrossRefPubMed
25.
Zurück zum Zitat S. Spaderna, O. Schmalhofer, F. Hlubek, G. Berx, A. Eger, S. Merkel, A. Jung, T. Kirchner, T. Brabletz, A transient, emt-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 131, 830–840 (2006)CrossRefPubMed S. Spaderna, O. Schmalhofer, F. Hlubek, G. Berx, A. Eger, S. Merkel, A. Jung, T. Kirchner, T. Brabletz, A transient, emt-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 131, 830–840 (2006)CrossRefPubMed
26.
Zurück zum Zitat U. Wellner, J. Schubert, U.C. Burk, O. Schmalhofer, F. Zhu, A. Sonntag, B. Waldvogel, C. Vannier, D. Darling, A. Zur Hausen, V.G. Brunton, J. Morton, O. Sansom, J. Schuler, M.P. Stemmler, C. Herzberger, U. Hopt, T. Keck, S. Brabletz, T. Brabletz, The emt-activator zeb1 promotes tumorigenicity by repressing stemness-inhibiting micrornas. Nat. Cell Biol. 11, 1487–1495 (2009)CrossRefPubMed U. Wellner, J. Schubert, U.C. Burk, O. Schmalhofer, F. Zhu, A. Sonntag, B. Waldvogel, C. Vannier, D. Darling, A. Zur Hausen, V.G. Brunton, J. Morton, O. Sansom, J. Schuler, M.P. Stemmler, C. Herzberger, U. Hopt, T. Keck, S. Brabletz, T. Brabletz, The emt-activator zeb1 promotes tumorigenicity by repressing stemness-inhibiting micrornas. Nat. Cell Biol. 11, 1487–1495 (2009)CrossRefPubMed
27.
Zurück zum Zitat H. Guan, G. Wei, J. Wu, D. Fang, Z. Liao, H. Xiao, M. Li, Y. Li, Down-regulation of mir-218-2 and its host gene slit3 cooperate to promote invasion and progression of thyroid cancer. J. Clin. Endocrinol. Metab. 98, E1334–E1344 (2013)CrossRefPubMed H. Guan, G. Wei, J. Wu, D. Fang, Z. Liao, H. Xiao, M. Li, Y. Li, Down-regulation of mir-218-2 and its host gene slit3 cooperate to promote invasion and progression of thyroid cancer. J. Clin. Endocrinol. Metab. 98, E1334–E1344 (2013)CrossRefPubMed
28.
Zurück zum Zitat Cancer Genome Atlas Research, Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–1068 (2008)CrossRef Cancer Genome Atlas Research, Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–1068 (2008)CrossRef
29.
Zurück zum Zitat B.P. Lewis, C.B. Burge, D.P. Bartel, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell 120, 15–20 (2005)CrossRefPubMed B.P. Lewis, C.B. Burge, D.P. Bartel, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell 120, 15–20 (2005)CrossRefPubMed
31.
Zurück zum Zitat J. Hou, L. Lin, W. Zhou, Z. Wang, G. Ding, Q. Dong, L. Qin, X. Wu, Y. Zheng, Y. Yang, W. Tian, Q. Zhang, C. Wang, Q. Zhang, S.M. Zhuang, L. Zheng, A. Liang, W. Tao, X. Cao, Identification of mirnomes in human liver and hepatocellular carcinoma reveals mir-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19, 232–243 (2011)CrossRefPubMed J. Hou, L. Lin, W. Zhou, Z. Wang, G. Ding, Q. Dong, L. Qin, X. Wu, Y. Zheng, Y. Yang, W. Tian, Q. Zhang, C. Wang, Q. Zhang, S.M. Zhuang, L. Zheng, A. Liang, W. Tao, X. Cao, Identification of mirnomes in human liver and hepatocellular carcinoma reveals mir-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19, 232–243 (2011)CrossRefPubMed
32.
Zurück zum Zitat T. Iwaya, T. Yokobori, N. Nishida, R. Kogo, T. Sudo, F. Tanaka, K. Shibata, G. Sawada, Y. Takahashi, M. Ishibashi, G. Wakabayashi, M. Mori, K. Mimori, Downregulation of mir-144 is associated with colorectal cancer progression via activation of mtor signaling pathway. Carcinogenesis 33, 2391–2397 (2012)CrossRefPubMed T. Iwaya, T. Yokobori, N. Nishida, R. Kogo, T. Sudo, F. Tanaka, K. Shibata, G. Sawada, Y. Takahashi, M. Ishibashi, G. Wakabayashi, M. Mori, K. Mimori, Downregulation of mir-144 is associated with colorectal cancer progression via activation of mtor signaling pathway. Carcinogenesis 33, 2391–2397 (2012)CrossRefPubMed
33.
Zurück zum Zitat Y. Guo, L. Ying, Y. Tian, P. Yang, Y. Zhu, Z. Wang, F. Qiu, J. Lin, Mir-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J. 280, 4531–4538 (2013)CrossRefPubMed Y. Guo, L. Ying, Y. Tian, P. Yang, Y. Zhu, Z. Wang, F. Qiu, J. Lin, Mir-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J. 280, 4531–4538 (2013)CrossRefPubMed
34.
Zurück zum Zitat S.M. Park, A.B. Gaur, E. Lengyel, M.E. Peter, The mir-200 family determines the epithelial phenotype of cancer cells by targeting the e-cadherin repressors zeb1 and zeb2. Genes Dev. 22, 894–907 (2008)CrossRefPubMedCentralPubMed S.M. Park, A.B. Gaur, E. Lengyel, M.E. Peter, The mir-200 family determines the epithelial phenotype of cancer cells by targeting the e-cadherin repressors zeb1 and zeb2. Genes Dev. 22, 894–907 (2008)CrossRefPubMedCentralPubMed
35.
Zurück zum Zitat Y. Arima, H. Hayashi, M. Sasaki, M. Hosonaga, T.M. Goto, T. Chiyoda, S. Kuninaka, T. Shibata, H. Ohata, H. Nakagama, Y. Taya, H. Saya, Induction of zeb proteins by inactivation of rb protein is key determinant of mesenchymal phenotype of breast cancer. J. Biol. Chem. 287, 7896–7906 (2012)CrossRefPubMedCentralPubMed Y. Arima, H. Hayashi, M. Sasaki, M. Hosonaga, T.M. Goto, T. Chiyoda, S. Kuninaka, T. Shibata, H. Ohata, H. Nakagama, Y. Taya, H. Saya, Induction of zeb proteins by inactivation of rb protein is key determinant of mesenchymal phenotype of breast cancer. J. Biol. Chem. 287, 7896–7906 (2012)CrossRefPubMedCentralPubMed
36.
Zurück zum Zitat J. Braun, C. Hoang-Vu, H. Dralle, S. Huttelmaier, Downregulation of micrornas directs the emt and invasive potential of anaplastic thyroid carcinomas. Oncogene 29, 4237–4244 (2010)CrossRefPubMed J. Braun, C. Hoang-Vu, H. Dralle, S. Huttelmaier, Downregulation of micrornas directs the emt and invasive potential of anaplastic thyroid carcinomas. Oncogene 29, 4237–4244 (2010)CrossRefPubMed
37.
Zurück zum Zitat A. Hebrant, G. Dom, M. Dewaele, G. Andry, C. Tresallet, E. Leteurtre, J.E. Dumont, C. Maenhaut, mrna expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch. PLoS One 7, e37807 (2012)CrossRefPubMedCentralPubMed A. Hebrant, G. Dom, M. Dewaele, G. Andry, C. Tresallet, E. Leteurtre, J.E. Dumont, C. Maenhaut, mrna expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch. PLoS One 7, e37807 (2012)CrossRefPubMedCentralPubMed
38.
Zurück zum Zitat C. Montemayor-Garcia, H. Hardin, Z. Guo, C. Larrain, D. Buehler, S. Asioli, H. Chen, R.V. Lloyd, The role of epithelial mesenchymal transition markers in thyroid carcinoma progression. Endocr. Pathol. 24, 206–212 (2013)CrossRefPubMed C. Montemayor-Garcia, H. Hardin, Z. Guo, C. Larrain, D. Buehler, S. Asioli, H. Chen, R.V. Lloyd, The role of epithelial mesenchymal transition markers in thyroid carcinoma progression. Endocr. Pathol. 24, 206–212 (2013)CrossRefPubMed
39.
Zurück zum Zitat F. De Amicis, A. Perri, D. Vizza, A. Russo, M.L. Panno, D. Bonofiglio, C. Giordano, L. Mauro, S. Aquila, D. Tramontano, S. Ando, Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines. J. Cell. Physiol. 228, 2054–2062 (2013)CrossRefPubMed F. De Amicis, A. Perri, D. Vizza, A. Russo, M.L. Panno, D. Bonofiglio, C. Giordano, L. Mauro, S. Aquila, D. Tramontano, S. Ando, Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines. J. Cell. Physiol. 228, 2054–2062 (2013)CrossRefPubMed
40.
Zurück zum Zitat X. Meng, D.H. Kong, N. Li, Z.H. Zong, B.Q. Liu, Z.X. Du, Y. Guan, L. Cao, H.Q. Wang, Knockdown of bag3 induces epithelial-mesenchymal transition in thyroid cancer cells through zeb1 activation. Cell Death Dis. 5, e1092 (2014)CrossRefPubMedCentralPubMed X. Meng, D.H. Kong, N. Li, Z.H. Zong, B.Q. Liu, Z.X. Du, Y. Guan, L. Cao, H.Q. Wang, Knockdown of bag3 induces epithelial-mesenchymal transition in thyroid cancer cells through zeb1 activation. Cell Death Dis. 5, e1092 (2014)CrossRefPubMedCentralPubMed
Metadaten
Titel
Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2
verfasst von
Hongyu Guan
Weiwei Liang
Zhiwei Xie
Hai Li
Juan Liu
Liehua Liu
Lingling Xiu
Yanbing Li
Publikationsdatum
01.03.2015
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2015
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0326-7

Weitere Artikel der Ausgabe 2/2015

Endocrine 2/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.